Tamarly Intelligence
Private raises · SEC Form D

EyeMacular Regeneration, Inc.: $3 million Raised, SEC Form D Filings

Company · Biotechnology · MN · incorporated 2023 · SEC CIK 2042485

Form D notices

A Form D tells the SEC that an issuer sold securities without a public offering. Amounts are as the issuer reported them; an amendment updates an earlier notice.

FiledTypeOfferingSoldIndustry
25 Sept 2026Amendment$6 million$3 millionBiotechnologyForm D
9 Oct 2025Amendment$6 million$2 millionBiotechnologyForm D

Questions and answers

How much has EyeMacular Regeneration, Inc. raised?
EyeMacular Regeneration, Inc. reported $3 million sold in its largest Form D notice on file; its latest notice was filed on 25 September 2026. Form D amounts are what the issuer reported to the SEC.
What is EyeMacular Regeneration, Inc.?
EyeMacular Regeneration, Inc. is a company in biotechnology, based in St. Paul, Minnesota, incorporated in 2023, according to its SEC Form D filings.
How many Form D notices has EyeMacular Regeneration, Inc. filed?
2 notices between 9 October 2025 and 25 September 2026 in Tamarly's record, which starts on 1 October 2025.
Get an alert when EyeMacular Regeneration, Inc. files again, and see every Form D raise as it arrives; the 7-day trial opens everything.Start the free trial

Source: SEC EDGAR, Form D (public domain). Cite this page: Tamarly Intelligence, "EyeMacular Regeneration, Inc.: SEC Form D filings", https://app.tamarly.ai/raisers/2042485, built from SEC EDGAR.

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.